AAAAAA

   
Results: 1-12 |
Results: 12

Authors: VANDUIJNHOVEN E CHRISTIAANS M SCHAFER A UNDRE N VANHOOFF J
Citation: E. Vanduijnhoven et al., TACROLIMUS DOSING REQUIREMENTS IN DIABETIC AND NONDIABETIC PATIENTS CALCULATED FROM PRETRANSPLANTATION DATA, Transplantation proceedings, 30(4), 1998, pp. 1266-1267

Authors: VANDUIJNHOVEN E CHRISTIAANS M UNDRE N STEVENSON P VANHOOFF J
Citation: E. Vanduijnhoven et al., THE EFFECT OF BREAKFAST ON THE ORAL BIOAVAILABILITY OF TACROLIMUS IN DIABETIC AND NONDIABETIC PATIENTS BEFORE TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1268-1270

Authors: CHRISTIAANS M VANDUIJNHOVEN E BEYSENS T UNDRE N SCHAFER A VANHOOFF J
Citation: M. Christiaans et al., EFFECT OF BREAKFAST ON THE ORAL BIOAVAILABILITY OF TACROLIMUS AND CHANGES IN PHARMACOKINETICS AT DIFFERENT TIMES POSTTRANSPLANT IN RENAL-TRANSPLANT RECIPIENTS, Transplantation proceedings, 30(4), 1998, pp. 1271-1273

Authors: UNDRE NA VANHOOFF J CHRISTIAANS M VANRENTERGHEM Y DONCK J HEEMAN U KOHNLE M ZANKER B LAND W MORALES JM ANDRES A SCHAFER A STEVENSON P
Citation: Na. Undre et al., PHARMACOKINETICS OF FK-506 AND MYCOPHENOLIC-ACID AFTER THE ADMINISTRATION OF A FK 506-BASED REGIMEN IN COMBINATION WITH MYCOPHENOLATE MOFETIL IN KIDNEY-TRANSPLANTATION, Transplantation proceedings, 30(4), 1998, pp. 1299-1302

Authors: CHRISTIAANS M OVERHOF R NIEMAN F VANHOOFF H VANDENBERGLOONEN E
Citation: M. Christiaans et al., FLOW-CYTOMETRY CROSS-MATCHES - THE MOST SENSITIVE RISK FACTOR FOR RENAL GRAFT-SURVIVAL IS THE RELATIVE CHANGE IN FLUORESCENCE RATIO (RCFR), Human immunology, 55, 1997, pp. 13-13

Authors: VANDENBERGLOONEN E CHRISTIAANS M VOORTER C VANHOOFF H
Citation: E. Vandenbergloonen et al., THE EFFECT OF HIGH-RESOLUTION DRB1 TYPING IN RENAL-TRANSPLANTATION, Human immunology, 55, 1997, pp. 128-128

Authors: MAYER AD DMITREWSKI J SQUIFFLET JP BESSE T GRABENSEE B KLEIN B EIGLER FW HEEMANN U PICHLMAYR R BEHREND M VANRENTERGHEM Y DONCK J VANHOOFF J CHRISTIAANS M MORALES JM ANDRES A JOHNSON RWG SHORT C BUCHHOLZ B REHMERT N LAND W SCHLEIBNER S FORSYTHE JLR TALBOT D NEUMAYER HH HAUSER I ERICZON BG BRATTSTROM C CLAESSON K MUHLBACHER F POHANKA E
Citation: Ad. Mayer et al., MULTICENTER RANDOMIZED TRIAL COMPARING TACROLIMUS (FK506) AND CYCLOSPORINE IN THE PREVENTION OF RENAL-ALLOGRAFT REJECTION - A REPORT OF THEEUROPEAN TACROLIMUS-MULTICENTER-RENAL-STUDY-GROUP, Transplantation, 64(3), 1997, pp. 436-443

Authors: CHRISTIAANS M WEIDEMANN P IKONOMOV V SCHUETZ N MELZER H VANHOOFF H MANN H LEUNISSEN K
Citation: M. Christiaans et al., GLOMERULAR AND TUBULAR DAMAGE ARE REVERSIBLE IN THE FIRST YEAR POST RENAL-TRANSPLANT AND ITS TIME-COURSE IS INDEPENDENT OF THE USE OF FK506OR CYCLOSPORINE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 425-425

Authors: CHRISTIAANS M BEYSENS T SPIERING W UNDRE N VANHOOFF H
Citation: M. Christiaans et al., EFFECT OF FOOD ON ORAL BIOAVAILABILITY OF TACROLIMUS AND CHANGES IN PHARMACOKINETICS WITH TIME POST RENAL-TRANSPLANT, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3187-3187

Authors: CHRISTIAANS M SPIERING W NIEMAN F WOLFFENBUTTEL B VANHOOFF H
Citation: M. Christiaans et al., GLUCOSEMETABOLISM, INSULIN AND C-PEPTIDE SECRETION CAPACITY IN THE FIRST YEAR AFTER RENAL-TRANSPLANTATION - EVEN STRESSED NO DIFFERENCE BETWEEN FK506 AND CYCLOSPORINE-A, Journal of the American Society of Nephrology, 7(9), 1996, pp. 3414-3414

Authors: SCHLEIBNER S KRAUSS M WAGNER K ERHARD J CHRISTIAANS M VANHOOFF J BUIST L MAYER D
Citation: S. Schleibner et al., FK-506 VERSUS CYCLOSPORINE IN THE PREVENTION OF RENAL-ALLOGRAFT REJECTION EUROPEAN PILOT-STUDY - 6-WEEK RESULTS, Transplant international, 8(2), 1995, pp. 86-90

Authors: CHRISTIAANS M VANDENBERGLOONEN E TENHAAFT A NIEMAN F VANHOOFF J
Citation: M. Christiaans et al., EFFECT OF FLOW-CYTOMETRY, COMPLEMENT-DEPENDENT CYTOTOXICITY, AND AUTOCROSS-MATCH ON CADAVERIC RENAL-TRANSPLANT OUTCOME, Transplantation proceedings, 27(1), 1995, pp. 1028-1030
Risultati: 1-12 |